| |
Latest 10 SEC filings (by transaction date) for ALLK within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 7/24 | Mar 6/24 | Radford Harlan Baird | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -32,142 | $1.35 |
Mar 6/24 | Mar 5/24 | Tomasi Adam | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -47,392 | $1.44 |
Mar 6/24 | Mar 4/24 | Alexander Robert | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -70,910 | $1.48 |
Feb 21/24 | Feb 16/24 | Radford Harlan Baird | Direct Ownership | Stock Option (Right to buy) | A - Grant, award or other under Rule 16b-3(d) | 900,000 | |
Feb 21/24 | Feb 16/24 | Tomasi Adam | Direct Ownership | Stock Option (Right to buy) | A - Grant, award or other under Rule 16b-3(d) | 1,200,000 | |
Feb 21/24 | Feb 16/24 | Alexander Robert | Direct Ownership | Stock Option (Right to buy) | A - Grant, award or other under Rule 16b-3(d) | 2,000,000 | |
Feb 21/24 | Feb 16/24 | Lee Chin Hyok | Direct Ownership | Stock Option (Right to buy) | A - Grant, award or other under Rule 16b-3(d) | 500,000 | |
Feb 16/24 | Feb 16/24 | Lee Chin Hyok | Direct Ownership | Stock Option (Right to buy) | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Feb 16/24 | Feb 16/24 | Lee Chin Hyok | Direct Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Jan 26/24 | Jan 26/24 | Bvf Partners L P/Il | Direct Ownership | Common Stock, $0.001 par value | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for ALLK within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 7/24 | Mar 6/24 | Radford Harlan Baird | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -32,142 | $1.35 |
Mar 6/24 | Mar 5/24 | Tomasi Adam | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -47,392 | $1.44 |
Mar 6/24 | Mar 4/24 | Alexander Robert | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -70,910 | $1.48 |
Feb 21/24 | Feb 16/24 | Radford Harlan Baird | Direct Ownership | Stock Option (Right to buy) | A - Grant, award or other under Rule 16b-3(d) | 900,000 | |
Feb 21/24 | Feb 16/24 | Tomasi Adam | Direct Ownership | Stock Option (Right to buy) | A - Grant, award or other under Rule 16b-3(d) | 1,200,000 | |
Feb 21/24 | Feb 16/24 | Alexander Robert | Direct Ownership | Stock Option (Right to buy) | A - Grant, award or other under Rule 16b-3(d) | 2,000,000 | |
Feb 21/24 | Feb 16/24 | Lee Chin Hyok | Direct Ownership | Stock Option (Right to buy) | A - Grant, award or other under Rule 16b-3(d) | 500,000 | |
Feb 16/24 | Feb 16/24 | Lee Chin Hyok | Direct Ownership | Stock Option (Right to buy) | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Feb 16/24 | Feb 16/24 | Lee Chin Hyok | Direct Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Jan 26/24 | Jan 26/24 | Bvf Partners L P/Il | Direct Ownership | Common Stock, $0.001 par value | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |